Successful Use of Dexmedetomidine for Sedation in a 24-Week Gestational Age Neonate

Abstract

Spanish

French

Objective:

To describe a case of dexmedetomidine use for sedation in a 24-week gestational age premature neonate.

Case Summary:

A 9-day-old, 24-week gestational age male neonate on high-frequency oscillatory mechanical ventilation was experiencing severe agitation refractory to high-dose intravenous narcotics and benzodiazepines. Since the infant's respiratory stability was reliant on adequate sedation, he was given dexmedetomidine after several days of suboptimal response to escalation of standard agents. Treatment prior to dexmedetomidine included continuous-infusion fentanyl 10 μg/kg/h, intravenous lorazepam 0.6 mg/kg every 4 hours, intermittent doses of both lorazepam and midazolam as needed, and a single bolus dose of phenobarbital. The patient calmed markedly during the dexmedetomidine loading dose infusion and remained adequately sedated while the drug was continued. The dexmedetomidine infusion allowed weaning of mechanical ventilation settings and eventual extubation of the infant, as well as rapid tapering of other sedative medications. The maximum dexmedetomidine infusion rate was 0.7 μg/kg/h, and total duration of therapy was 19 days. No significant adverse effects were directly attributed to dexmedetomidine use during this time.

Discussion:

Dexmedetomidine is a novel α2-agonist approved for short-term sedation in mechanically ventilated adults. Data describing its use in pediatric and neonatal patients continue to emerge. The prolonged use of dexmedetomidine in very-low-birth-weight neonates has not been described in the literature.

Conclusions:

Dexmedetomidine was an effective sedative and analgesic in a 24-week gestational age neonate treated for refractory agitation while on mechanical ventilation. Based on its documented efficacy for pain and sedation and its favorable adverse effect profile, dexmedetomidine warrants further study as first-line or adjunct therapy with narcotics for sedation in ventilated newborns.

Keywords

dexmedetomidine premature neonate sedation

Get full access to this article

View all access options for this article.

References

Tobias

, Berkenbasch

. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004; 97:451–5. DOI 10.1097/00007611-200405000-00007

Barton

, Munoz

, Morell

, Chrysostomou

. Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr Crit Care Med 2008; 9:612–5. DOI 10.1097/PCC.0b013e31818d320d

Walker

, Maccallum

, Fischer

, Kopcha

, Saylors

, McCall

. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006; 27:206–10. DOI 10.1097/01.J3CR.0000200910.76019.CF

Lubisch

, Roskos

, Sattler

. Improving outcomes in pediatric procedural sedation. Jt Comm J Qual Saf 2008; 34:192–5.

Zub

, Berkenbosch

, Tobias

. Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Paediatr Anaesth 2005; 15:932–8. DOI 10.1111/j.1460-9592.2005.01623.x

Tobias

. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children. J Opioid Manag 2008; 4:187–91.

Finkel

, Johnson

, Quezado

. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005; 33:2110–2. DOI 10.1097/01.CCM.00001781832188323

Munro

, Tirotta

, Felix

. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Paediatr Anaesth 2007; 17:109–12. DOI 10.1111/j.1460-9592.2006.02031.x

Mason

, Zurakowski

, Zgleszewski

. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008; 18:403–11. DOI 10.1111/j.1460-9592.2008.02468.x

10.

Ibacache

, Munoz

, Brandes

, Morales

. Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children. Anesth Analg 2004; 98:60–3. DOI 10.1213/01.ANE.0000094947.20838.8E

11.

Isik

, Arslan

, Tunga

, Kurtipek

. Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery. Paediatr Anaesth 2006; 16:748–53. DOI 10.1111/J.1460-9592.2006.01845.X

12.

Khasawinah

, Ramirez

, Berkenbosch

, Tobias

. Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome. Am J Ther 2003; 10:303–7. DOI 10.1097/00045391-200307000-00012

13.

Venn

, Hell

, Grounds

. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4:302–8. Epub 31 Jul 2000. DOI 10.1186/cc712

14.

Memis

, Dokmeci

, Karamanlioglu

, Turan

, Ture

. A comparison of the effect on gastric emptying of propofol or dexmedetomidine in critically ill patients: preliminary study. Eur J Anaesthesiol 2006; 23:700–4. DOI 10.1017/S0265021506000512

15.

, Hossain

, Rajakumaraswamy

. Dexmedetomidine produces neuroprotective effects via the α_2A-receptor subtype. Eur J Pharmacol 2004; 502:87–97.

16.

Roberts

, Dalziel

. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3:CD004454. DOI 10.1002/14651858.CD004454.pub2

17.

Soraisham

, Singhal

, McMillan

, Sauve

, Lee

. Canadian Neonatal Network. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol 2009; 200:372e1–372e6. Epub 14 Feb 2009 (accessed 2009 Jan 26). DOI 10.1016/j.ajog.2008.11.034

18.

Taddio

, Shah

, Atenafu

, Katz

. Influence of repeated painful procedures and sucrose analgesia on the development of hyperalgesia in newborn infants. Pain 2009; 144:43–8. Epub 28 Mar 2009. DOI 10.1016/j.pain.2009.02.012

19.

. Is there a “normal” range of serum cortisol concentrations for preterm infants? Pediatr 2008; 122:873–5. DOI 10.1542/peds.2008-0516

20.

Odd

, Armstrong

, Teele

, Kuschel

, Harding

. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity. J Paediatr Child Health 2004; 40:282–9. DOI 10.1080/14767050500363519

21.

McCrea

, Ment

. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008; 35:777–92. DOI 10.1016/j.clp.2008.07.014

22.

Bekkali

, Hamers

, Schipperus

. Duration of meconium passage in preterm and term infants. Arch Dis Child Fetal Neonatal Ed 2008; 93:F376–9. Epub 19 Feb 2008. DOI 10.1136/adc.2008.138024

23.

Greenholz

, Perez

, Wesley

, Marr

. Meconium obstruction in markedly premature infant. J Pediatr Surg 1996; 31:117–2. DOI 10.1016/S0022-3468(96)90332-22

24.

Simmons

, Anand

. Pain control: opioid dosing, population kinetics, and side effects. Semin Fetal Neonatal Med 2006; 11:260–7. Epub 18 Apr 2006. DOI 10.1016/j.siny.2006.02.008

25.

Richman

, Baram

, Varela

, Glass

. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination. Crit Care Med 2006; 34:e1395–401. Epub 14 Apr 2008 (accessed 2009 Jan 26). DOI 10.1097/01.CCM.0000215454.50964.F8

26.

Darnell

, Thompson

, Stromberg

, Roy

, Sheeran

. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children. Pediatr 2008; 121:1363–71. DOI 10.1542/peds.2007-1468

27.

Lam

, Alexander

. Dexmedetomidine use in critical care. AACN Adv Crit Care 2008; 19:113–20. DOI 10.1097/01.AACN.0000318109.0607335

28.

Bejian

, Valasek

, Nigro

, Cleveland

, Willis

. Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit. Cardiol Young 2009; 19:98–104. Epub 20 Jan 2009. DOI 10.1017/S1047951109003515

29.

Riker

, Shehabi

, Bokesch

. Dexmedetomidine versus midazolam for sedation of critically ill patients. JAMA 2009; 301:489–99. Epub 2 Feb 2009. DOI 10.1001/jama.2009.56

30.

Reiter

, Pietras

, Dobyns

. Prolonged dexmedetomidine infusions in critically ill infants and children. Indian Pediatr. Epub 1 Apr 2009 (accessed 2009 May 20).

31.

Dominguez

, Lomako

, Katz

, Kelly

. Opioid withdrawal in critically ill neonates. Ann Pharmacother 2003; 37:473–7. Epub 28 Feb 2003. DOI 10.1345/aph.1C324

32.

Enomoto

, Kudo

, Saito

. Prolonged use of dexmedetomidine in an infant with respiratory failure following living liver donor transplantation. Paediatr Anaesth 2006; 16:1285–8. DOI 10.1111/j.1460-9592.2006.02008.x

33.

Hsu

Y-W

, Cortinez

, Robertson

. Dexmedetomidine pharmacodynamics: part I: crossover comparison of respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesth 2004; 101:1066–76. DOI 10.1097/00000542-200411000-00005

34.

Bhana

, Goa

, McClellan

. Dexmedetomidine. Drugs 2000; 59:263–8. DOI 102165/00003495-200059020-00012

35.

Potts

, Warman

, Anderson

. Dexmedetomidine disposition in children: a population analysis. Pediatr Anesth 2008; 18:722–30. DOI 10.1111/j.1460-9592.2008.02653.x

36.

Vilo

, Rautiainen

, Kaisti

. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. Br J Anaesth 2008; 100:697–700. DOI 10.1093/bja/aen070

37.

Cosar

, Eser

, Fidan

. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol 2009; 71:54–9. Epub 22 Jan 2008. DOI 10.1016/j.surneu.2007.08.020

38.

Eser

, Fidan

, Sahin

. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 2008; 1218:250–6. Epub 27 Apr 2008. DOI 10.1016/j.brainres.2008.04.045

39.

Kuhmonen

, Pokorny

, Miettinen

. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997; 87:371–7.

40.

Mellon

, Simone

, Rappaport

. Use of anesthetic agents in neonates and young children. Anesth Analg 2007; 104:509–20. DOI 10.1213/01.ane.0000255729.96438.b0

41.

Anand

, Hall

, Desai

. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomized trial. Lancet 2004; 263:1673–82. DOI 10.1016/S0140-6736(04)16251-X

42.

Rao

, Sampers

, Kronsberg

, Brown

, Desai

, Anand

. Neurobehavior of preterm infants at 36 weeks postconception as a function of morphine analgesia. Am J Perinatol 2007; 24:511–7. DOI 10.1055/s-2007-986675

43.

Maze

, Virtanen

, Daunt

, Banks

, Stover

, Feldman

. Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and vitro studies. Anesth Analg 1991; 73:204–8. DOI 10.1213/00000539-199108000-00015

44.

Czaja

, Zimmerman

. The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med 2009; 10:381–6. DOI 10.1097/PCC.0b013e3181a3191f

45.

Carroll

, Krieger

, Campbell

, Fisher

, Comeau

, Zucker

. Use of dexmedetomidine for sedation of children hospitalized in the intensive care unit. J Hosp Med 2008; 3:142–7. DOI 10.1002/jhm.282

46.

Watterberg

, Gerdes

, Gifford

, Lin

. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999; 104:1258–63. DOI 10.1542/peds.104.6.1258

47.

Watterberg

, Scott

, Backstrom

, Gifford

, Cook

. Links between early adrenal insufficiency and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 2000; 105:320–4. DOI 10.1542/peds.105.2.320

48.

Watterberg

, Gerdes

, Cole

. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114:1649–57. DOI 10.1542/peds.2004-11